Association of common CRP gene variants with CRP levels and cardiovascular events

D T Miller1, R Y L Zee, J Suk Danik

  • 1Division of Hematology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

Annals of Human Genetics
|November 4, 2005
PubMed

Insights

Genetic variations in C-reactive protein (CRP) influence its levels, a key marker for cardiovascular disease risk. Some CRP gene variants are linked to higher or lower CRP levels, but not directly to heart attack or stroke risk.

Area of Science:

  • Genetics
  • Cardiovascular Disease
  • Biomarkers

Background:

  • C-reactive protein (CRP) is a recognized indicator of atherosclerotic cardiovascular disease (ASCVD) risk.
  • Understanding genetic contributions to CRP levels is crucial for risk assessment.

Purpose of the Study:

  • To identify common single nucleotide polymorphism (SNP) variants within the CRP gene.
  • To investigate the association of these SNPs with baseline CRP levels in multiple healthy cohorts.
  • To determine if CRP-associated SNPs correlate with the risk of myocardial infarction (MI) or ischemic stroke.

Main Methods:

  • Resequencing of the CRP gene to identify common SNP variants.
  • Association studies in three independent cohorts: Women's Health Study (WHS), Pravastatin Inflammation/CRP Evaluation (PRINCE), and Physicians' Health Study (PHS).
  • Prospective, nested case-control study within the PHS cohort to assess incident cardiovascular events.

Main Results:

  • Four SNPs were consistently associated with higher CRP levels, and two with lower CRP levels across all cohorts (p < 0.05).
  • Functional roles suggested for the 5'-flanking SNP -286C>T>A and the 3'-UTR SNP 1846G>A.
  • No identified CRP-level-associated SNPs predicted risk of MI or ischemic stroke.
  • One SNP, -717A>G, unrelated to CRP levels, showed association with decreased MI risk (p = 0.001).

Conclusions:

  • Genetic variations significantly influence CRP levels, a predictor of atherothrombotic events.
  • The relationship between CRP levels and cardiovascular risk involves complex interactions between genetic and environmental factors.
  • Specific CRP SNPs may not directly mediate cardiovascular risk despite their effect on CRP levels.

Related Concept Videos

Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...